Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)

PHASE2UnknownINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

May 2, 2022

Primary Completion Date

August 31, 2024

Study Completion Date

December 31, 2024

Conditions
Alcohol Use Disorder
Interventions
DRUG

Psilocybin

Psilocybin and psychotherapy

DRUG

Placebo

Placebo and psychotherapy

Trial Locations (12)

45100

A-Klinikka, Kouvola

T3C 0J7

Sabi Mind, Calgary

Unknown

Okanagan Clinical Trials, Kelowna

Centre for Neurology Studies, Surrey

Department of Psychiatry, Queen's University, Kingston

Research Center Oxidi Oy / Addiktum Oy, Helsinki

Mentacare Oy, Oulu

Addiktum Oy, Turku

V6T 1Z3

University of British Columbia, Department of Psychiatry, BRAIN Lab, Vancouver

B3S 1N2

Centricity Research, Halifax

L8S 1B7

MacAnxiety Research Centre, Hamilton

M6J 1H4

Centre for Addiction and Mental Health, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
lead

Clairvoyant Therapeutics

INDUSTRY

collaborator

Optimapharm

INDUSTRY

NCT05646303 - Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD) | Biotech Hunter | Biotech Hunter